Study finds relationship between diabetes and OSA cofactors in development of CVD.
Read More »HbA1c Variability and Risk of All-Cause Mortality and Cardiovascular Events
Study assesses effect of variable glycemic levels on risk of vascular complication in patients without diabetes.
Read More »Effect of Elevated Triglycerides on Glycemic Management by Patients with Type 2 Diabetes
Study attempts to determine association between elevated triglyceride levels and achieving glycemic goals for those with insulin-treated diabetes.
Read More »People with Type 2 at Risk with Use of Sulfonylureas as Second-Line Medication
Drugs shown to increase risk of hypoglycemic and cardiovascular events.
Read More »Liraglutide Lowers Risk of Cardiovascular Events In Type 2 Diabetes
GLP-1 treatment benefits patients on statins and with varying LDL levels.
Read More »Albiglutide’s Effect on Cardiovascular Outcomes in People with Type 2 Diabetes
Study looks at convenient once-weekly GLP-1 that can reduce chances of heart attacks and strokes.
Read More »How Effective Are Statins for Patients 75 and Older?
Current therapy recommendations may need adjustment.
Read More »Childhood Diabetes Lowers Lifespan by 18 Years
Researchers suggest implementation of cardioprotective medications sooner than current guideline recommendations.
Read More »Safety and Efficacy of Lorcaserin
New study focuses on cardiovascular safety of weight loss drug in patients with excess weight or obesity.
Read More »Biomarkers to Predict Cardiovascular Events in People with Type 2 Diabetes
The SUMMIT VIP study shows conventional risk factors do not suffice in predicting heart complications.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.